Feature Rotating Article - BioPharm International

ADVERTISEMENT

Feature Rotating Article

Report from India

February 1, 2013

India's biopharmaceutical industry is valued at $2 billion a year with 20 companies producing biosimilars and 50 products available in the domestic market.

Assessing Development Needs for Biobetters and Biosimilars

February 1, 2013

Development requirements and regulatory guidance for biosimilars and biobetters.

Viral Vaccine Manufacturing

February 1, 2013

Tony Hitchcock of Cobra Biologics discusses challenges posed by production of viral vectors for vaccines.

Navigating Emerging Markets: Eastern Europe

February 1, 2013

Eastern Europe is moving towards a goal of harmonized regulations.

Polishing Complex Therapeutic Proteins

January 1, 2013

A new downstream purification platform using a salt-tolerant membrane adsorber.

Biologics: What Does the Future Hold?

January 1, 2013

Neil Lewis, chief technology officer at Malvern Instruments, talks about the challenges associated with biologics.

Epigenetics Drives Pharma Innovation

January 1, 2013

Therapeutics targeting epigenetic mechanisms of disease will change the pharmaceutical marketplace.

Bioconjugates: The Adaptable Challenge

January 1, 2013

Conjugation of a biologic to a carrier molecule can solve problems in solubility and stability, but introduces its own challenges.

A Look Ahead at BioPharma Manufacturing and Regulation

January 1, 2013

FDA talks about the changing scope of regulatory science.

ADVERTISEMENT

ADVERTISEMENT

Click here